The Future of Rare Disease Commercialization Won’t Be Defined by Access Alone Biopharmaceutical companies invest years of development, millions of dollars, and extraordinary scientific expertise to bring rare disease therapies to market. Yet many continue to evaluate pharmacy partners using criteria built for a different era. Distribution. Dispensing. Fulfillment. While those capabilities remain essential, they are no longer enough. Which […]
Diabetes has become one of the most significant healthcare challenges facing health plans today. What was once viewed primarily as a chronic medical condition is now a complex population health issue that impacts quality performance, healthcare costs, member satisfaction, and long-term outcomes. [cdc.gov] More than 40 million Americans are currently living with diabetes, representing approximately […]
SMYRNA, GEORGIA, Aug. 18, 2026 - Curant Health has been named a 2026 Atlanta Top Workplace and Healthcare Top Workplace by Axios, earning additional Cultural Excellence honors for Work-Life Flexibility, Purpose & Values, Professional Development, Leadership, Innovation, and Appreciation. The recognition reflects Curant Health’s commitment to building an employee-centered culture where people are empowered to grow, innovate, and make […]
Real-world data is essential to understanding how therapies perform beyond clinical trials, particularly in rare diseases like Niemann-Pick disease type C (NPC). As healthcare increasingly prioritizes evidence that reflects everyday patient experience, the need for meaningful patient-reported outcomes continues to grow. In collaboration with IntraBio, Curant Rare developed a first-of-its-kind real-world evidence (RWE) system that […]
PlanPlus by Curant Health Serves Security Health Plan Heart Failure Members and Significantly Reduces Total Cost of Care in One Year. Authors: Jeremy Combs, MBA1 (Corresponding author: jcombs@curanthealth.com) John Cox, MD2 Paula Jacobson3 Executive Summary In 2023, Security Health Plan (SHP) partnered with PlanPlus by Curant Health to address rising Total Cost of Care (TCOC) among members diagnosed with Congestive Heart Failure (CHF). Heart failure is one of […]
Each year, Medicare Stars cut points continue to rise, and 2026 is no exception. Nearly 60% of all cut points increased year over year, including approximately 60% of 4-Star thresholds, further reinforcing how challenging it has become to achieve and sustain high performance. As expectations continue to climb, plans must shift from reactive adjustments to […]
Atlanta, GA – Curant Rare today announced a strategic collaboration with Cencora, a global pharmaceutical solutions organization, that aims to provide pharmaceutical companies developing rare disease therapies with an integrated solution to support the commercialization of their products. Rare disease therapies face unique challenges, including complex regulatory pathways and access barriers. This collaboration will leverage Cencora’s pharmaceutical logistics services and commercialization solutions, such as pharmacovigilance and market access support, and Curant Rare’s specialty pharmacy services and omnichannel patient engagement solutions. The integrated solution aims to streamline […]
ATLANTA--(BUSINESS WIRE)--Curant Health is proud to announce that Curant Rare has been selected by Corcept Therapeutics as a specialty pharmacy to provide personalized care, coordinated access to therapy, and comprehensive support to help patients and caregivers navigate the complexities of treatment. Patients will now benefit from Curant Rare’s proven high-touch care model, designed to ensure […]
Atlanta, GA – August 18, 2025 – Curant Health is proud to announce that Curant Rare is now the exclusive pharmacy partner for IWILFIN™, a groundbreaking therapy used to reduce the risk of relapse in adults and children with high-risk neuroblastoma (HRNB). Beginning in August 2025, patients will transition to Curant Rare with one clear […]
WICHITA, Kan.--(BUSINESS WIRE)--Curant Health, a leading national specialty pharmacy serving communities for over 25 years, officially announces the opening of its new on-site pharmacy at The University of Kansas School of Medicine-Wichita Medical Practice Association. This new location seeks to enhance patient convenience and deliver comprehensive care by seamlessly combining doctor visits with pharmacy services. […]
